The three-day event featured 80 research presentations, 3 keynote lectures, and several special sessions and workshops ...

Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in adeno-associated virus (AAV) gene therapy, today announced a major expansion of its artificial intelligence and machine learning ...

Hyderabad- and Cambridge-based biotech startup Helex will use the capital to advance its gene therapy platform and develop ...

When Sean Fletcher walked into Sam Biswas' Medical and Molecular Sciences (MMSC) lab at the University of Delaware College of Health Sciences ...

Developer tools provider VoidZero, fintech platform SalarySe, biotech startup Helex and several other companies have ...

A vaccine that tackles the bacteria that cause up to 200 million childhood infections every year could be possible, experts say.In the first study of ...

The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...

Helex raises $3.5 million seed round led by pi Ventures to advance targeted gene therapies for kidney diseases: Our Bureau, Bengaluru Friday, October 31, 2025, 12:30 Hrs [IST] Hel ...

Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed with our AI-Immunology platformEVX-04 is a therapeutic cancer vaccine candidate ...

The American University in Cairo (AUC) has introduced a series of innovative academic programs, including a new sustainable energy minor,  a genomics an ...

A $483,620 federal grant will transform how Spelman College prepares the next generation of biomedical scientists. Mentewab Ayalew, Ph.D., a professor of biology, has secured three years of funding ...